Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients

ChiCTR, ChiCTR2000029758. Registered 12 February 2020 - Retrospectively registered

Detalles Bibliográficos
Autores principales: Ma, Aijia, Cheng, Jiangli, Yang, Jing, Dong, Meiling, Liao, Xuelian, Kang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273815/
https://www.ncbi.nlm.nih.gov/pubmed/32503668
http://dx.doi.org/10.1186/s13054-020-03007-0
_version_ 1783542480266854400
author Ma, Aijia
Cheng, Jiangli
Yang, Jing
Dong, Meiling
Liao, Xuelian
Kang, Yan
author_facet Ma, Aijia
Cheng, Jiangli
Yang, Jing
Dong, Meiling
Liao, Xuelian
Kang, Yan
author_sort Ma, Aijia
collection PubMed
description ChiCTR, ChiCTR2000029758. Registered 12 February 2020 - Retrospectively registered
format Online
Article
Text
id pubmed-7273815
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72738152020-06-05 Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients Ma, Aijia Cheng, Jiangli Yang, Jing Dong, Meiling Liao, Xuelian Kang, Yan Crit Care Research Letter ChiCTR, ChiCTR2000029758. Registered 12 February 2020 - Retrospectively registered BioMed Central 2020-06-05 /pmc/articles/PMC7273815/ /pubmed/32503668 http://dx.doi.org/10.1186/s13054-020-03007-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Letter
Ma, Aijia
Cheng, Jiangli
Yang, Jing
Dong, Meiling
Liao, Xuelian
Kang, Yan
Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients
title Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients
title_full Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients
title_fullStr Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients
title_full_unstemmed Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients
title_short Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients
title_sort neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ards in severe covid-19 patients
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273815/
https://www.ncbi.nlm.nih.gov/pubmed/32503668
http://dx.doi.org/10.1186/s13054-020-03007-0
work_keys_str_mv AT maaijia neutrophiltolymphocyteratioasapredictivebiomarkerformoderatesevereardsinseverecovid19patients
AT chengjiangli neutrophiltolymphocyteratioasapredictivebiomarkerformoderatesevereardsinseverecovid19patients
AT yangjing neutrophiltolymphocyteratioasapredictivebiomarkerformoderatesevereardsinseverecovid19patients
AT dongmeiling neutrophiltolymphocyteratioasapredictivebiomarkerformoderatesevereardsinseverecovid19patients
AT liaoxuelian neutrophiltolymphocyteratioasapredictivebiomarkerformoderatesevereardsinseverecovid19patients
AT kangyan neutrophiltolymphocyteratioasapredictivebiomarkerformoderatesevereardsinseverecovid19patients

Ejemplares similares